About this trial
This study evaluates the pulse oximetry (SpO₂) sensor for clinical performance, form, and fit in hospitalized infants and children (28 days to 12 years). It compares SpO₂ measurements from the device to arterial oxygen saturation (SaO₂) values from arterial CO-oximetry, and assesses the reliability of usable data, performance across skin tones, and user feedback.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
subjects are 1-23 months (infant cohort) or 2-12 years old (child cohort)
requiring arterial blood samples per the site's standard of care.
Disqualifiers
Fractional Methemoglobinemia (FMetHb >2%) or Fractional carboxyhemoglobinemia (FCOHb >3%), within 24 hours of arterial blood draw.
Severe anemia (tHb <7g/dL) within 4 hours prior to arterial blood gas draw.
Hematocrit (Hct) <25 within 4 hours prior to arterial blood gas draw.
Patients with injuries, deformities, or abnormalities which may prevent proper application of the sensor.
Trial design
Single group
Treatments tested in this trial
SpO2 Sensor
DeviceSpO2 sensors use red and infrared LED light to estimate the arterial oxygen saturation.
Treatment groups
Trial outcomes
Primary outcomes
Collection of SpO2 Percentage Sensor Data with simultaneous SaO2 values
The collection of SpO2 percentage sensor data with simultaneous SaO2 values percentage from each subject enrolled in the study.
Other outcomes
Incidence of Safety Events
Analysis of adverse events will be listed per subject, summarized with counts and percentages of events, and summarized with counts and percentages of subjects with events.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: